Skip to main content

Table 2 Characteristics of subjects included in the echocardiographic study

From: The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome

Variables

Non-MetS (n = 62)

MetS (n = 68)

P value

Age, years

48.7 ± 7.0

51.9 ± 9.4

0.0351

Male, n (%)

31 (50.0)

37 (54.4)

0.4669

Hypertension, n (%)

0 (0)

58 (85.3)

–

Diabetes mellitus, n (%)

5 (8.1)

49 (72.1)

< 0.0001

BMI, kg/m2

22.7 ± 3.0

29.0 ± 3.8

< 0.0001

Waist circumference, cm

78.2 ± 8.5

97.8 ± 9.7

< 0.0001

Hip circumference, cm

95.2 ± 6.5

103.9 ± 8.6

< 0.0001

Systolic BP, mmHg

116.4 ± 10.3

142.8 ± 20.7

< 0.0001

Diastolic BP, mmHg

71.2 ± 7.9

87.2 ± 14.4

< 0.0001

Heart rate, beats/min

73.9 ± 9.2

85.0 ± 13.8

< 0.0001

Electrocardiogram Parameters

 P, msec

105.6 ± 14.2

108.9 ± 13.2

0.1872

 PR, msec

156.2 ± 24.9

167.6 ± 20.0

0.0064

 Terminal force of P, mVS

1.6 ± 1.5

1.7 ± 1.6

0.8157

 QRS, msec

85.7 ± 10.8

88.5 ± 16.5

0.2735

 QTc, msec

405.0 ± 21.5

405.5 ± 37.8

0.9292

Echocardiographic Parameters

 Aorta diameter, cm

3.2 ± 0.3

3.4 ± 0.4

0.0012

 LA diameter, cm

3.4 ± 0.5

3.9 ± 0.5

< 0.0001

 LA volume, mL

48.9 ± 15.4

70.6 ± 18.2

< 0.0001

 LVEDD, cm

4.6 ± 0.5

4.8 ± 0.5

0.0049

 LVEDV, mL

95.9 ± 30.4

126.0 ± 37.2

< 0.0001

 LV mass, gram

107.7 ± 23.7

133.7 ± 28.8

< 0.0001

 EF, %

63.9 ± 11.3

67.3 ± 7.1

0.0515

 E/E’ (med)

7.7 ± 2.3

9.8 ± 2.7

< 0.0001

 E/E’ (lat)

5.8 ± 2.2

6.7 ± 1.8

0.0169

 Valve disease, n (%)

0

0

–

  1. BMI Body mass index, BP Blood pressure, LA Left atrium, LVEDD Left ventricle end-diastolic dimension, LVEDV Left ventricle end-diastolic volume, LVEF Left ventricle ejection fraction, E/E’ (med) The ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (E’) at medial mitral ring, E/E’ (lat) The ratio of mitral peak velocity of early filling (E) to early diastolic mitral annular velocity (E’) at the lateral mitral ring